19th CUA Genitourinary Oncology Conference | Professor Baojun Wang: Breaking Through the Bottlenecks in Prostate Cancer Treatment—Balancing Clinical Innovation with Standardized Care

19th CUA Genitourinary Oncology Conference | Professor Baojun Wang: Breaking Through the Bottlenecks in Prostate Cancer Treatment—Balancing Clinical Innovation with Standardized Care

The 19th Chinese Urological Association (CUA) Genitourinary Oncology Conference was held in Beijing on July 3–4, 2026, under the theme "Advancing Frontiers, Standardizing Care, and Driving Collaborative Innovation." The meeting brought together leading experts in urologic oncology from across China to examine the current challenges facing the field and explore future directions for clinical research and patient care.
19th CUA Genitourinary Oncology Conference | Professor Xuesong Li: Advancing the UTUC Subspecialty Through High-Quality Research to Address Key Clinical Challenges

19th CUA Genitourinary Oncology Conference | Professor Xuesong Li: Advancing the UTUC Subspecialty Through High-Quality Research to Address Key Clinical Challenges

The 19th Chinese Urological Association (CUA) Genitourinary Oncology Conference was held in Beijing on July 3–4, 2026, bringing together leading experts from across China under the theme "Advancing Frontiers, Standardizing Care, and Driving Collaborative Innovation." The meeting provided a platform for discussing new directions in urologic oncology research and clinical practice.
19th CUA Genitourinary Oncology Conference | Professor Kan Gong: Taking a Pragmatic View of AI in Clinical Practice While Building a China-Specific Evidence Base for Urologic Oncology

19th CUA Genitourinary Oncology Conference | Professor Kan Gong: Taking a Pragmatic View of AI in Clinical Practice While Building a China-Specific Evidence Base for Urologic Oncology

The 19th Chinese Urological Association (CUA) Genitourinary Oncology Conference was successfully held in Beijing on July 3–4, 2026. Centered on the theme "Advancing Frontiers, Standardizing Care, and Driving Collaborative Innovation," the meeting featured in-depth discussions on precision oncology, early screening and prevention of prostate cancer, and the development of a robust domestic clinical research ecosystem, highlighting both the latest advances and the key challenges facing urologic oncology in China.